BML reports 6,669,908 shares (9.95%) in enGene
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BML Investment Partners, L.P. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 6,669,908 common shares of enGene Holdings Inc. The filing states these shares represent 9.95% of the class as of the report and lists shared voting and shared dispositive power over those shares. The filing identifies the reporting person as BML Investment Partners, L.P. (a Delaware limited partnership) and discloses that BML Capital Management, LLC and Braden M. Leonard are indirect owners/agents with signature dated 05/14/2026.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does BML Investment Partners report in ENGN?
When was the Schedule 13G/A amendment for ENGN signed?
Who is reported as having control or indirect ownership in the ENGN filing?
What CUSIP and class are referenced in the ENGN filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.